Security key
Y95308105
Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE)
CUSIP: Y95308105
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Ordinary Shares, no par value
- Total 13F shares
- 172,478,533
- Total 13F value
- $1,247,355,027
- Share change
- -10,620,214
- Put/Call ratio
- 31%
- SEC-reported price per share
- $7.25
- Number of holders
- 226
- Value change
- -$203,869,620
- Number of buys
- 146
- Number of sells
- 84
- Shares outstanding
- 188,679,245
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q1 2026
Institutions
226
Top holders
10
WVE full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
Wave Life Sciences Ltd. SEC filings
Wave Life Sciences Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP Y95308105
Recent filing periods:
Ownership snapshot
Top reported holders of WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
GSK plc
Comparable rows
15/15
Latest evidence
31 Mar 2026
13F
13D/G
3/4/5
Lead comparable stake: 6.1%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 6.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
BlackRock, Inc.
6.1%
MAVERICK CAPITAL LTD
5.4%
FMR LLC
2.8%
Adage Capital Management, L.P.
0.53%
Peter Kolchinsky
14%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
6.1%
from 13D/G
|
$215,031,419
12,648,907 shares
|
— | 31 Dec 2025 |
| MAVERICK CAPITAL LTD |
13F
13D/G
Company
|
5.4%
from 13D/G
|
$157,764,029
9,280,237 shares
|
— | 31 Dec 2025 |
| FMR LLC |
13F
13D/G
Company
|
2.8%
from 13D/G
|
$257,311,705
15,135,983 shares
|
— | 31 Dec 2025 |
| Adage Capital Management, L.P. |
13D/G
|
0.53%
|
$7,180,000
1,000,000 shares
|
-$63,083,918 | 31 Mar 2026 |
| Peter Kolchinsky |
3/4/5
Director, 10%+ Owner
|
14%
|
$175,340,782
26,975,505 shares
|
+$54,624,378 | 26 Mar 2026 |
| RA Capital Healthcare Fund LP |
3/4/5
Director, 10%+ Owner
|
14%
|
$175,340,782
26,975,505 shares
|
+$54,624,378 | 26 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
226
Shares
172,478,533
Rows available
226
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
218
Q1 2026 holders
226
Holder diff
8
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend